Person: ALTIPARMAK, ÖZNUR
Loading...
Email Address
Birth Date
Research Projects
Organizational Units
Job Title
Last Name
ALTIPARMAK
First Name
ÖZNUR
Name
3 results
Search Results
Now showing 1 - 3 of 3
Publication Open Access Reliability of high-alert medications questionnaire in Turkish healthcare professionals(2022-01-01) ALTIPARMAK, ÖZNUR; SANCAR, MESUT; OKUYAN, BETÜL; Ozturk F., Altiparmak O., Torun B., Bektay M. Y., SANCAR M., OKUYAN B.Objective: This study aimed to evaluate the reliability of the HighAlert Medications (HAM) Questionnaire in Turkish healthcare professionals. Methods: This methodological study was conducted between December 2017 and January 2018 in a private university hospital. The healthcare professionals, including nurses, health service technicians, and pharmacists, who are older than 18 years old were eligible for this study. After following the appropriate translation and cultural adaptation process, the internal consistency of the HAM Questionnaire using the Kuder-Richardson 20 coefficient and test-retest reliability was evaluated. Results: Among 146 healthcare professionals, the mean age was 25.40±5.16 years, wherein 76% were females. Most participants were nurses (69.9%) and other healthcare professionals were health service technicians (28.1%) and pharmacists (2.0%). The mean total score of the HAM Questionnaire was 70.00±19.50. The KuderRichardson 20 was 0.815. A statistically significant correlation was found between the scores of the HAM Questionnaire at baseline and after 15 days, which confirmed the test-retest reliability (r=0.527; p<0.01). A statistically significant correlation was found between the HAM Questionnaire score and advanced age (r=0.310; p<0.001) and higher professional year (r=0.445; p<0.001). Conclusion: The Turkish version of the HAM Questionnaire could be used to assess healthcare professionals’ knowledge about highalert medications.Publication Open Access Medication Review in Turkish Older Adults at Community Pharmacy: A Pilot Study by Using Medication Appropriateness Index(2022-09-01) ALTIPARMAK, ÖZNUR; SANCAR, MESUT; OKUYAN, BETÜL; Dal S., Ucar N., ALTIPARMAK Ö., SANCAR M., OKUYAN B.Objective: The study aimed to evaluate medication review in older adults (≥65 years) at a community pharmacy by identifying the prevalence of potentiality inappropriate medication and calculating medication appropriateness index. Methods: This descriptive study was carried out in a community pharmacy for six months. The older adults (≥65 years) using one or more medications were included. During clinical pharmacist-led medication review; the medication appropriateness index was calculated for each medication of older adults. Potentially inappropriate medications were evaluated according to the 2019 American Geriatrics Society Beers Criteria®. Result: Among a hundred older adults, 46.0% were female. The median age of the patients was 75.5 (IQR, 68.0-78.8). The median number of medications was 9.0 (7.0-10.0). Polypharmacy has been detected in 97.0% of the patients. At least one potentially inappropriate medication was detected in 63.0% of them. The median score of medication appropriateness index score was 53.0 (IQR: 38.6-67.9). Conclusion: To best our knowledge, this is the first study of clinical pharmacist-led medication review by calculating the medication appropriateness index carried out at a community pharmacy in Turkey. There was a high rate of potentially inappropriate medication with a higher score of medication appropriateness in older adults. This study highlights the importance of medication review led by the clinical pharmacist at community pharmacy to optimize medication usage in older adults. Keywords: Older adults, clinical pharmacist, medication appropriateness index, potentially inappropriate medicationPublication Metadata only Prescribing patterns of potentially inappropriate medication use in older patients in Europe: the results from the EUROAGEISM H2020 project(2022-12-01) ALTIPARMAK, ÖZNUR; OKUYAN, BETÜL; Brkic J., Drzaic M., Kummer I., Hadziabdic M. O., Sesto S., Tadic I., Altiparmak O., OKUYAN B., Bobrova V., Volmer D., et al.